ニトログリセリンはセプティックショックの治療薬です.

Same author

Is Early Vasopressor Administration Really Not Important in Septic Shock?

Annals of emergency medicine·2026

Same author

The role of hemoadsorption in septic shock: toward a personalized approach.

Critical care (London, England)·2026

Same author

The new SOFA for sepsis identification and mortality prediction: a multicenter cohort study.

Journal of intensive care·2026

Same author

The IMPACT framework for evaluating generative AI in critical care: development and multinational consensus validation.

Annals of intensive care·2026

Same author

European Society of Intensive Care Medicine Clinical Practice Guideline on fluid therapy in adult critically ill patients: A path toward improved patient management.

Journal of intensive medicine·2026

Same author

Delayed presentation of air embolism after removal of central venous catheters: A systematic review.

Journal of critical care·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

関連する実験動画

ニトログリセリンはセプティックショックの治療薬です.

関連する概念動画

Is Early Vasopressor Administration Really Not Important in Septic Shock?

The role of hemoadsorption in septic shock: toward a personalized approach.

The new SOFA for sepsis identification and mortality prediction: a multicenter cohort study.

The IMPACT framework for evaluating generative AI in critical care: development and multinational consensus validation.

European Society of Intensive Care Medicine Clinical Practice Guideline on fluid therapy in adult critically ill patients: A path toward improved patient management.

Delayed presentation of air embolism after removal of central venous catheters: A systematic review.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

関連する実験動画

ニトログリセリンはセプティックショックの治療薬です.

関連する概念動画

関連記事

Is Early Vasopressor Administration Really Not Important in Septic Shock?

The role of hemoadsorption in septic shock: toward a personalized approach.

The new SOFA for sepsis identification and mortality prediction: a multicenter cohort study.

The IMPACT framework for evaluating generative AI in critical care: development and multinational consensus validation.

European Society of Intensive Care Medicine Clinical Practice Guideline on fluid therapy in adult critically ill patients: A path toward improved patient management.

Delayed presentation of air embolism after removal of central venous catheters: A systematic review.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.